Tropical Disease Development Partnerships Want More Help From U.S. FDA
This article was originally published in PharmAsia News
The agency’s infrastructure is not attracting many of the Product Development Partnership sponsors, Aeras official says, but new draft guidance could help.
You may also be interested in...
Inspection Fees Face Tough Road In Congress As PhRMA Remains Opposed
At user fee hearing, PhRMA’s Wheadon counters questions from Rep. Dingell, saying FDA already is receiving resources to conduct GMP inspections outside the U.S.
Foreign Regulator Exchange Program Contemplated By U.S. State Department
FDA has its own programs, but a State Department undersecretary said enhancing training at FDA could boost efforts to fight drug counterfeiting and diversion.
Good Neighbors Make Good Regulatory Science Centers, FDA Decides
Georgetown, Maryland gain CERSI grants in part because of their proximity to agency staff.